12.04.2023 / Deals & Cases
Deal: TriNetX acquires Clinerion through a strategic partnership with Norstella
Wenger Vieli advised TriNetX, a portfolio company of Carlyle, on its acquisition of Clinerion, a Swiss-based subsidiary of Norstella. Through a new multi-faceted, long-term agreement Norstella with Clinerion and TriNetX expand the world's leading research network for real-world data (RWD) and are on a mission to create 'one of the most complete real-world data footprints in the pharmaceutical industry.' (Theodore Search, GM, Norstella)
Clinerion, headquartered in Basel, is a worldwide leader in medical data informatics, improving efficiency in treatments for patients and accelerating clinical research. Its network spans over more than 75 healthcare organizations across 25 countries.
Norstella unites market-leading pharmaceutical solutions providers that have a shared goal of helping patients gain access to life-saving therapies.
TriNetX is a global network of healthcare organizations and life sciences companies driving real-world research to accelerate the development of novel therapies.
The team was led by Beat Speck (Partner, Corporate M&A) and included Michèle Joho-Menotti (Senior Associate, Corporate M&A), Philipp Baumann (Associate, Corporate M&A), Mark Stocker (Associate, Employment), Cyrill Barmettler (Junior Lawyer) and Pharin Mos Wyler (Junior Lawyer).